Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE

Rankning i aktier #4273
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aktiekurs
$51.39
Senast synkroniserad: 2026-10-21
Marknadsvärde
$3.67B
Förändring (1 dag)
1.09%
Förändring (1 år)
197.94%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)

Kategori

Healthcare
Historik för aktiesplit för Pulse Biosciences, Inc. (PLSE)
Aktien Pulse Biosciences, Inc. (symbol: PLSE) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 22, 2026.
En PLSE-aktie köpt före Oct 22, 2026 motsvarar nu 0 PLSE-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH